On January 4, 2018 Syros Pharmaceuticals (NASDAQ: SYRS), a biopharmaceutical company pioneering the development of medicines to control the expression of genes, reported that its Chief Executive Officer, Nancy Simonian, M.D., will present a corporate overview, including 2018 objectives, at the 36th Annual J.P. Morgan Healthcare Conference (Press release, Syros Pharmaceuticals, JAN 4, 2018, View Source [SID1234522895]). Details are as follows:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
36th Annual J.P. Morgan Healthcare Conference
Date: Thursday, January 11
Time: 10:30 a.m. PST (1:30 p.m. EST)
Location: Westin St. Francis Hotel, 335 Powell St., San Francisco, CA
The presentation will be followed by a question and answer session.
A live webcast of the presentation and question and answer session will be available on the Investors & Media section of the Syros website at www.syros.com. An archived replay of the webcast will be available for approximately 30 days following the presentation.